Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Ulcerative Colitis”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableEnrolling By InvitationNCT07257588
What this trial is testing

The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD

Who this might be right for
Ulcerative Colitis
Xijing Hospital of Digestive Diseases 44
Large-scale testing (Phase 3)Looking for participantsNCT06660693
What this trial is testing

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
McMaster University 134
Testing effectiveness (Phase 2)Ended earlyNCT01375179
What this trial is testing

Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients

Who this might be right for
Ulcerative Colitis
Novartis Pharmaceuticals 27
Not applicableStudy completedNCT03460847
What this trial is testing

Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa

Who this might be right for
Colitis, Ulcerative
Medical University of Graz 114
Large-scale testing (Phase 3)WithdrawnNCT00502294
What this trial is testing

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis

Who this might be right for
Intravenous Steroid-Refractory Ulcerative Colitis
Facet Biotech 150
Early research (Phase 1)Study completedNCT04987333
What this trial is testing

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Who this might be right for
Inflammatory Diseases
Amgen 32
Large-scale testing (Phase 3)Ended earlyNCT00279435
What this trial is testing

Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study

Who this might be right for
Ulcerative Colitis
Facet Biotech 25
Very early researchStudy completedNCT03268213
What this trial is testing

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis

Who this might be right for
Clostridium Difficile InfectionUlcerative ColitisIndeterminate Colitis
Stony Brook University 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297069
What this trial is testing

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

Who this might be right for
Acute Severe Ulcerative Colitis
Asian Institute of Gastroenterology, India 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07513181
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
Athos Therapeutics Inc 120
Testing effectiveness (Phase 2)Ended earlyNCT03986996
What this trial is testing

Antimicrobial Therapy for Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Wolfson Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01771809
What this trial is testing

Long-Term Safety Of PF-00547659 In Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 330
Very early researchUnknownNCT05239702
What this trial is testing

Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisDermatomyositis+2 more
Zhejiang University 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07544160
What this trial is testing

BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)

Who this might be right for
Inflammatory Bowel Diseases (IBD)
iCell Gene Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT03760003
What this trial is testing

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 355
Not applicableStudy completedNCT05728008
What this trial is testing

Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
IRCCS San Raffaele 100
Not applicableLooking for participantsNCT07198113
What this trial is testing

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Who this might be right for
Ulcerative Colitis, PediatricInflammatory Bowel DiseasesCrohn Disease
University of North Carolina, Chapel Hill 1,100
Post-approval studies (Phase 4)Study completedNCT01481142
What this trial is testing

Adacolumn in Refractory UC Patients Trial

Who this might be right for
Ulcerative Colitis, Active Moderate
Otsuka Pharmaceutical Europe Ltd 100
Not applicableEnded earlyNCT02734589
What this trial is testing

Fecal Transplantation Using a Diet for Donor and Recipient in Refractory Colitis

Who this might be right for
Ulcerative Colitis
Wolfson Medical Center 54
Large-scale testing (Phase 3)Study completedNCT01493960
What this trial is testing

The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients

Who this might be right for
Colitis, Ulcerative
InDex Pharmaceuticals 131
Load More Results